Lv11
80 积分 2025-10-22 加入
A targeted approach to phosphoinositide-3-kinase/Akt/mammalian target of rapamycin-induced hyperglycemia
4小时前
待确认
Capivasertib: A Novel AKT Inhibitor Approved for Hormone-Receptor-Positive, HER-2-Negative Metastatic Breast Cancer
5小时前
已完结
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
3个月前
已完结
Impact of a five-dimensional framework on R&D productivity at AstraZeneca
3个月前
已完结
Lessons Learned from Targeting IGF-I Receptor in Thyroid-Associated Ophthalmopathy
3个月前
已完结
Designing the next generation of clinical trials in intermediate AMD-a consensus driven, pragmatic, proof of concept early intervention study
4个月前
已关闭
Clinicogenomic landscape and function of PIK3CA , AKT1 , and PTEN mutations in breast cancer
4个月前
已完结
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study
5个月前
已完结
POS0230 DISAGREEMENT BETWEEN PATIENT AND PHYSICIAN GLOBAL ASSESSMENT OVER TIME IN PSORIATIC ARTHRITIS: INSIGHT INTO TREATMENT PRIORITIES
6个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
6个月前
已完结
皖公网安备34019202002308
